Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
Authors:
- Paul TurnerPTPaul Turner
- Andrew Fox-LewisAFAndrew Fox-Lewis
- Poojan ShresthaPSPoojan Shrestha
- David A. B. DanceDavid A. B. Dance
- Tri WangrangsimakulTWTri Wangrangsimakul
- Tomas-Paul CusackTCTomas-Paul Cusack
- Clare L. LingCLClare L. Ling
- Jill HopkinsJHJill Hopkins
- Tamalee RobertsTRTamalee Roberts
- Direk LimmathurotsakulDirek Limmathurotsakul
- Ben S. CooperBCBen S. Cooper
- Susanna DunachieSDSusanna Dunachie
Open Access
- 29 March 2019
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 17 (1) , 1-8
Abstract
There is a pressing need to understand better the extent and distribution of antimicrobial resistance on a global scale, to inform development of effective interventions. Collation of datasets for meta-analysis, mathematical modelling and temporo-spatial analysis is hampered by the considerable variability in clinical sampling, variable quality in laboratory practice and inconsistencies in antimicrobial susceptibility testing and reporting. The Microbiology Investigation Criteria for Reporting Objectively (MICRO) checklist was developed by an international working group of clinical and laboratory microbiologists, infectious disease physicians, epidemiologists and mathematical modellers. In keeping with the STROBE checklist, but applicable to all study designs, MICRO defines items to be included in reports of studies involving human clinical microbiology data. It provides a concise and comprehensive reference for clinicians, researchers, reviewers and journals working on, critically appraising, and publishing clinical microbiology datasets. Implementation of the MICRO checklist will enhance the quality and scientific reporting of clinical microbiology data, increasing data utility and comparability to improve surveillance, grade data quality, facilitate meta-analyses and inform policy and interventions from local to global levels.Keywords
Funding Information
- Wellcome Trust (106698/Z/14/Z)
This publication has 23 references indexed in Scilit:
- Practical Guidance for Clinical Microbiology Laboratories: Implementing a Quality Management System in the Medical Microbiology LaboratoryClinical Microbiology Reviews, 2018
- Measuring and mapping the global burden of antimicrobial resistanceBMC Medicine, 2018
- Antimicrobial Resistance in Invasive Bacterial Infections in Hospitalized Children, Cambodia, 2007–2016Emerging Infectious Diseases, 2018
- Epidemiology and burden of multidrug-resistant bacterial infection in a developing countryeLife, 2016
- STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardshipBMJ Open, 2016
- Providing Impetus, Tools, and Guidance to Strengthen National Capacity for Antimicrobial Stewardship in Viet NamPLOS Medicine, 2013
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub‐Saharan Africa and Asian low and middle income countriesTropical Medicine & International Health, 2011
- Analysis and Presentation of Cumulative Antibiograms: A New Consensus Guideline from the Clinical and Laboratory Standards InstituteClinical Infectious Diseases, 2007
- Ability of Laboratories To Detect Emerging Antimicrobial Resistance: Proficiency Testing and Quality Control Results from the World Health Organization's External Quality Assurance System for Antimicrobial Susceptibility TestingJournal of Clinical Microbiology, 2001